United States News All stories

Travel + Leisure Co. (NYSE:TNL) reported third-quarter 2026 net revenue of $1.10 billion and adjusted diluted earnings of $2.21 per share, up 23% year over year.

Herc Holdings (NYSE:HRI) reported record third-quarter 2026 revenue of $1.364 billion, up 5% year over year, as equipment rental demand lifted earnings and margins.

Itron (NASDAQ:ITRI) reported third-quarter 2026 revenue of $599.3 million, up 3% year over year, while non-GAAP diluted earnings reached $1.94 per share, exceeding analyst expectations.

CMS Energy (NYSE:CMS) reported third-quarter 2026 adjusted earnings of $1.44 per share, up from $0.93 a year earlier, while reported diluted earnings fell to $0.39 per share.

Lincoln Electric Holdings (NASDAQ:LECO) reported third-quarter 2026 net sales of $1.221 billion, up 15.1% year over year, while adjusted earnings per share increased 21% to $2.98.

Amkor Technology (NASDAQ:AMKR) reported third-quarter 2026 revenue of $1.99 billion and GAAP earnings of $0.76 per share, missing analyst estimates for both measures.

Cadence Design Systems (NASDAQ:CDNS) reported third-quarter 2026 revenue of $1.63 billion, up 22% year over year, while adjusted earnings reached $2.11 per share.

Travelzoo (NASDAQ:TZOO) reported third-quarter 2026 revenue of $22.9 million, up 3% year over year, but recorded an operating loss of $2.6 million for the quarter ended September 30.

Boeing (NYSE:BA) reported third-quarter 2026 revenue of $24.19 billion, up 4% year over year, and narrowed its net loss to $116 million from $5.34 billion a year earlier.

Hilton Worldwide Holdings (NYSE:HLT) reported third-quarter 2026 adjusted earnings of $2.45 per share, beating the $2.35–$2.36 analyst consensus, while revenue increased 6.6% to $3.33 billion but missed forecasts of $3.36–$3.37 billion.

Corning (NYSE:GLW) reported third-quarter 2026 core revenue of $5.08 billion, up 19% year over year, and core earnings of $0.91 per share, beating analyst estimates of $5.03 billion and $0.88, respectively.

The Coca-Cola Company (NYSE:KO) reported third-quarter 2026 revenue of $13.4 billion, up 7% year over year, while adjusted earnings rose 11% to $0.91 per share, exceeding analysts’ $0.88 consensus estimate.

UPS (NYSE:UPS) reported third-quarter 2026 revenue of $22.9 billion, up 6.7% year over year, as growth across all business segments supported higher financial guidance.

Hycroft Mining Holding Corporation (NASDAQ:HYMC) reported $211 million in unrestricted cash and no debt in its third-quarter update, supporting continued exploration and development work at its Hycroft mining project.

AllianceBernstein Holding (NYSE:AB) reported third-quarter 2026 adjusted earnings of $0.88 per unit, up 2.3% year over year, as net revenues increased 7.8% to $1.226 billion.

Ares Capital (NASDAQ:ARCC) declared a fourth-quarter dividend of $0.48 per share as third-quarter GAAP net income fell to $319 million from $404 million a year earlier.

Daqo New Energy (NYSE:DQ) reported third-quarter 2026 revenue of $194.2 million as polysilicon shipments increased, narrowing its net loss to $52.9 million from $81.2 million in the previous quarter.

Smithfield Foods (NASDAQ:SFD) reported fiscal third-quarter operating profit of $127 million, down from $310 million a year earlier, as sales fell 8.3% to $3.4 billion for the quarter ended September 27, 2026.

Cementos Pacasmayo (NYSE:CPAC) reported third-quarter 2026 EBITDA of S/233.1 million, up 45.1% from the same quarter in 2025, as revenue and sales volumes increased.

Daiichi Sankyo and AstraZeneca (NASDAQ:AZN) received European Union approval for Enhertu as an adjuvant treatment for eligible adults with HER2-positive early breast cancer and residual invasive disease after neoadjuvant treatment.

NVIDIA (NASDAQ:NVDA) plans to invest $3 billion in Meta’s equity offering as the companies expand their collaboration on AI models, computing infrastructure and agent development.

Pharming Group (NASDAQ:PHAR) reported preliminary third-quarter 2026 revenue of $117.6 million, up 21% year over year, as operating profit rose 89% to $29.9 million.

Innate Pharma (NASDAQ:IPHA) announced that high-level data from the PACIFIC-9 Phase 3 trial are now expected in the first half of 2027, following a timeline revision by AstraZeneca (NYSE:AZN).

TechTarget (NASDAQ:TTGT), operating as Informa TechTarget, reported underlying revenue growth of -1.6% for the nine months ended September 30, 2026, as technology customers shifted spending priorities toward artificial intelligence.